Stanley Erck

Director/Board Member at MAXCYTE, INC.

Net worth: 527 361 $ as of 29/06/2026

78 year

64 connections

Health Technology

Consumer Services

Miscellaneous

Profile

Mr. Stanley C. Erck is a President, Chief Executive Officer & Director at Novavax, Inc. and an Independent Non-Executive Director at MaxCyte, Inc. He is on the Board of Directors at Novavax, Inc., MdBio Foundation and MaxCyte, Inc. Mr. Erck was previously employed as an Independent Director by BioCryst Pharmaceuticals, Inc., a President, Chief Executive Officer & Director by Iomai Corp., a Head-Global Regulatory Affairs Vaccines by Baxter International, Inc., a Vice President-Corporate Development by Integrated Genetics, Inc., and a President, Chief Executive Officer & Director by Procept, Inc. He received his undergraduate degree from the University of Illinois and an MBA from The University of Chicago Booth School of Business.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
MAXCYTE, INC. 0.4%	16/06/2026	428,749 ( 0.4% )	527 361 $	29/06/2026

Stanley Erck active positions

Companies	Position	Start
MAXCYTE, INC.	Director/Board Member	31/12/2004
Learning Undefeated, Inc. Learning Undefeated, Inc. Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment	Director/Board Member	12/05/2009

All active positions of Stanley Erck

Former positions of Stanley Erck

Companies	Position	End
NOVAVAX, INC.	Chief Executive Officer	22/01/2023
BIOCRYST PHARMACEUTICALS, INC.	Director/Board Member	02/12/2018
IOMAI CORPORATION	Chief Executive Officer	31/12/2007
Integrated Genetics, Inc. Integrated Genetics, Inc. Pharmaceuticals: MajorHealth Technology Engages in pharmaceuticals preparations	Corporate Officer/Principal	-
Procept, Inc. Procept, Inc. Pharmaceuticals: MajorHealth Technology Develops manufactures & markets drugs	Chief Executive Officer	-

See the detail of Stanley Erck's experience

Training of Stanley Erck

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Stanley Erck's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	10
Baxter International, Inc. Baxter International, Inc. Medical SpecialtiesHealth Technology Produces and supplies medical products, healthcare systems, therapies and pharmaceuticals & provide kidney care services	Health Technology
BioCryst Pharmaceuticals, Inc. BioCryst Pharmaceuticals, Inc. BiotechnologyHealth Technology Designs and develops oral small-molecule & injectable protein therapeutics	Health Technology
Novavax, Inc. Novavax, Inc. BiotechnologyHealth Technology Engages in development of novel recombinant vaccines	Health Technology
MaxCyte, Inc. MaxCyte, Inc. BiotechnologyHealth Technology Specializes in cell modification technologies to enable the discovery, development, manufacturing, and delivery of therapeutic products	Health Technology
Procept, Inc. Procept, Inc. Pharmaceuticals: MajorHealth Technology Develops manufactures & markets drugs	Health Technology
University of Illinois University of Illinois Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Intercell USA, Inc. Intercell USA, Inc. BiotechnologyHealth Technology Discovers and develops vaccines and immune system stimulants	Health Technology
Integrated Genetics, Inc. Integrated Genetics, Inc. Pharmaceuticals: MajorHealth Technology Engages in pharmaceuticals preparations	Health Technology
The University of Chicago Booth School of Business The University of Chicago Booth School of Business Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Learning Undefeated, Inc. Learning Undefeated, Inc. Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment	Miscellaneous